|
National Stock Number(NSN): 6505-01-056-0695 (6505010560695, 010560695)
| NIIN: |
01-056-0695 |
Item Name: |
SODIUM PHOSPHATES INJECTION |
INC: |
35493
|
| FSC: |
6505
|
Assignment Date: |
|
CRIT: |
|
IIG: |
35493 |
| ISC: |
5 |
Date Standardized: |
|
HMIC: |
|
DODIC: |
|
| NSC: |
5 |
Cancellation Date: |
May-01-1992 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
|
Originator: |
|
ADPEC: |
|
RPDMRC: |
|
| NIIN: |
01-354-8607 |
Item Name: |
SODIUM PHOSPHATES INJECTION |
| FSC: |
6505 |
Replacement Date: |
May-01-1992 |
|
INC: |
35493 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
17015-PX |
22630
|
INVENEX LABORATORIES LIFE TECHNOLOGIES INC |
H |
5 |
9 |
|
|
|
|
|
|
|
|
|
6505-01-C18-0679 |
89875
|
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
7391-01 |
60060
|
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00074-7391-01 |
60060
|
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00467-2170-25 |
22630
|
INVENEX LABORATORIES LIFE TECHNOLOGIES INC |
H |
5 |
9 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
H |
Z |
M |
|
1 |
|
$47.41 |
PG |
|
C2201X- |
|
H |
| DF |
S9M |
H |
|
M |
|
1 |
|
$47.41 |
PG |
|
------N |
|
H |
| DN |
S9M |
H |
|
M |
|
1 |
|
$47.41 |
PG |
|
9L----- |
|
H |
| DS |
S9M |
H |
|
M |
|
1 |
|
$47.41 |
PG |
|
------- |
|
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 50EA |
|
|
|
|
| DA |
R |
NOT DMSB STZD |
|
|
|
|
| DF |
K |
EDI 0000050EA |
|
|
|
|
| DF |
R |
NON-STD NON-DMSB REV |
|
|
|
|
| DN |
K |
NON-0000050EA |
|
|
|
|
| DN |
R |
NON-STD NON-DMSB REV |
|
|
|
|
| DN |
R |
EDI ITEM |
|
|
|
|
| DS |
K |
NOT 0000050EA |
|
|
|
|
| DS |
R |
NON-STD NON-DMSB REV |
|
|
|
|
| DS |
R |
EDI ITEM |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
EQUIV. TO 3 MILLIMOLES PHOSPHATE AND 3 MEQ. SODIUM PER ML. |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
15.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
50 |
| FEAT |
SPECIAL FEATURES |
15 ML. IN A 30 ML. VIAL |
| PKTY |
UNIT PACKAGE TYPE |
PACKAGE |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
|
3 |
Z |
|
|
|
|
| FSKX |
|
|
3 |
Z |
|
|
|
|
| N9LM |
|
|
3 |
Z |
|
|
|
|
|